Zymeworks' IPO

Zymeworks raised a round of funding on April 28, 2017. Investors include Public.

Zymeworks (NYSE: ZYME) (TSX: ZYME) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of multifunctional biotherapeutics.…

Articles about Zymeworks' IPO: